CURECA and STAgora technologies aim to eliminate manual intervention in molecular testing workflows and provide actionable diagnostic data insights.
Seegene Inc unveiled two pre-commercial technologies at ADLM 2025 designed to advance laboratory automation and data-driven infectious disease monitoring. The molecular diagnostics company introduced CURECA, billed as the world’s first fully unattended PCR automation system, and STAgora, a real-time data analytics platform for diagnostic insights.
The technologies address persistent challenges in molecular testing, where most systems remain only partially automated and dependent on skilled personnel for repetitive manual steps, according to the company.
“With CURECA and STAgora, we are taking an important step toward the future of diagnostics,” says Dr Jong-Yoon Chun, chairman and CEO of Seegene, in a release. “Our goal is to enable laboratories worldwide to automate complex testing workflows and use diagnostic data more effectively.”
Full Automation Addresses Pre-Treatment Bottleneck
CURECA is designed to fully automate every step of PCR testing, including the traditionally manual pre-treatment stage that has remained a barrier to complete automation. The system’s dedicated CURECA Prep module processes diverse specimen types including urine, blood, sputum, and stool samples.
The complete CURECA system handles the entire PCR workflow from sample loading through nucleic acid extraction, amplification and result analysis without manual intervention. The system is engineered for continuous 24-hour operation and aims to minimize human error while allowing laboratories to allocate skilled staff to higher-value activities.
Seegene notes that achieving true full automation requires three conditions: operation without highly trained professionals, continuous 24-hour processing, and uninterrupted specimen input. CURECA is designed to meet all three criteria.
The modular system can be configured for different laboratory sizes and workflows. Seegene says CURECA Prep could potentially extend to other testing fields including clinical chemistry and immunodiagnostics as the company explores broader automation applications.
Analytics Platform Provides Real-Time Clinical Intelligence
STAgora collects and analyzes PCR testing data in real time, providing laboratories with broader context to inform diagnostic workflows. The platform includes more than 40 analytical tools offering functions such as infection trend tracking, hospital-level positivity monitoring, and multi-pathogen co-infection pattern analysis.
Rather than serving as a data repository, STAgora is built as an integrated platform intended to help laboratories derive meaningful insights from testing data. The system enables hospitals to build statistical datasets and compare data across institutions to detect infection patterns and support decision-making.
Data shared through the platform is de-identified and formatted according to institutional requirements, supporting secure real-time exchange at local, national, or global levels, according to Seegene.
Industry Response and Commercial Timeline
Industry experts at ADLM 2025 expressed interest in the new technologies. “I’ve attended many ADLM conferences over the years, and CURECA is one of the most innovative solutions I have seen so far,” says Jamel Giuma, president and CEO of Miami-based laboratory IT consulting firm JTG Consulting Group, in a release. “I believe it has the potential to simplify laboratory workflows, reduce the burden on lab personnel, and greatly enhance overall operational efficiency.”
Chun says the introduction of CURECA and STAgora completes the company’s five core technology pillars, which include Seegene’s proprietary PCR technology, the SGDDS automated assay development system, its global Technology-Sharing Initiative, and now fully automated PCR testing and real-time data analytics capabilities.
Both CURECA and STAgora are pre-commercial technologies under development and are not commercially available or cleared for clinical diagnostic use in any jurisdiction. The company has not announced commercial availability timelines for either system.
Photo caption: Seegene showcases its unattended PCR automation system, CURECA, and infectious disease data analysis platform, STAgora, at ADLM 2025 in Chicago, July 29-31, 2025.
Photo credit: Seegene
